Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Virchows Archiv
Published in: Virchows Archiv 1/2018

01-01-2018 | Invited Annual Review Issue

Esophagitis unrelated to reflux disease: current status and emerging diagnostic challenges

Authors: Melanie E. Johncilla, Amitabh Srivastava

Published in: Virchows Archiv | Issue 1/2018

Login to get access

Abstract

There has been much progress in our understanding of esophageal inflammatory disorders in the past few years. This is particularly true about esophageal eosinophilia and PPI responsiveness, lymphocytic esophagitis and motility disorders, and short-term risk of neoplasia in esophageal leukoplakia. The current review will summarize esophageal injury patterns that primarily occur due to non-reflux causes, with a focus on usual pitfalls in biopsy diagnosis and recent advances in our knowledge of the more common forms of esophagitis.
Literature
1.
Wishingrad M (1999) Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. Gastrointest Endosc 50(6):845–846PubMedCrossRef
2.
Maiorana A et al (2003) Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol 34(12):1331–1336PubMedCrossRef
3.
Chen Z, Scudiere JR, Montgomery E (2009) Medication-induced upper gastrointestinal tract injury. J Clin Pathol 62(2):113–119PubMedCrossRef
4.
Parfitt JR, Driman DK (2007) Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 38(4):527–536PubMedCrossRef
5.
Abraham SC, Yardley JH, Wu TT (1999) Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol 23(10):1241–1247PubMedCrossRef
6.
Lee FD (1994) Drug-related pathological lesions of the intestinal tract. Histopathology 25(4):303–308PubMedCrossRef
7.
Boyce HW Jr (1998) Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc 47(6):547–550PubMedCrossRef
8.
Graham DY (2002) What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates. Dig Dis Sci 47(8):1665–1678PubMedCrossRef
9.
de Groen PC et al (1996) Esophagitis associated with the use of alendronate. N Engl J Med 335(14):1016–1021PubMedCrossRef
10.
Abraham SC et al (1999) Alendronate-associated esophageal injury: pathologic and endoscopic features. Mod Pathol 12(12):1152–1157PubMed
11.
12.
Uygun I et al (2012) Clinico-epidemiological study of caustic substance ingestion accidents in children in Anatolia: the DROOL score as a new prognostic tool. Acta Chir Belg 112(5):346–354PubMedCrossRef
13.
14.
Riffat F, Cheng A (2009) Pediatric caustic ingestion: 50 consecutive cases and a review of the literature. Dis Esophagus 22(1):89–94PubMedCrossRef
15.
Purdy JK, Appelman HD, McKenna BJ (2012) Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol 25(5):767–775PubMedCrossRef
16.
Carmack SW et al (2009) Esophagitis dissecans superficialis (“sloughing esophagitis”): a clinicopathologic study of 12 cases. Am J Surg Pathol 33(12):1789–1794PubMedCrossRef
17.
Trabulo D et al (2015) Esophageal stenosis with sloughing esophagitis: a curious manifestation of graft-vs-host disease. World J Gastroenterol 21(30):9217–9222PubMedPubMedCentralCrossRef
18.
Baum S, Sakka N, Artsi O et al (2014 Apr-May) Diagnosis and classification of autoimmune blistering diseases. Autoimmun Rev 13(4–5):482–489PubMedCrossRef
19.
Goldberg NS, Weiss SS (1989 Nov) Pemphigus vulgaris of the esophagus in women. J Am Acad Dermatol 21(5 Pt 2):1115–1118PubMedCrossRef
20.
Ahmadi B, DePasquale JR (2003) Esophageal bullous pemphigoid. Am J Gastroenterol 98:S214–S215
21.
Chang S, Park SJ, Kim SW et al (2014 Sep) Esophageal involvement of Pemphigus vulgaris associated with upper gastrointestinal bleeding. Clin Endosc 47(5):452–454PubMedPubMedCentralCrossRef
22.
23.
Liacouras CA et al (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128(1):3–20 e6 quiz 21-2PubMedCrossRef
24.
Straumann A et al (2012) Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 67(4):477–490PubMedCrossRef
25.
Furuta GT et al (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133(4):1342–1363PubMedCrossRef
26.
Molina-Infante J et al (2011) Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 9(2):110–117PubMedCrossRef
27.
Wen T et al (2015) Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 135(1):187–197PubMedCrossRef
28.
Dellon ES et al (2013) Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 108(12):1854–1860PubMedPubMedCentralCrossRef
29.
Moawad FJ et al (2013) Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol 108(3):366–372PubMedCrossRef
30.
Molina-Infante J et al (2014) Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther 40(8):955–965PubMedCrossRef
31.
Iwakura N et al (2015) Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther 41(8):776–784PubMedCrossRef
32.
Warners MJ et al (2015) PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. Eur J Gastroenterol Hepatol 27(5):506–511PubMedCrossRef
33.
Hirano I et al (2013) Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 62(4):489–495PubMedCrossRef
34.
Collins MH (2014) Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin N Am 43(2):257–268CrossRef
35.
Sayej WN et al (2009) Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 49(4):393–399PubMedCrossRef
36.
Isomoto H et al (2004) Mucosal concentrations of proinflammatory cytokines and chemokines at gastric cardia: implication of Helicobacter pylori infection and gastroesophageal reflux. Am J Gastroenterol 99(6):1063–1068PubMedCrossRef
37.
Wen T et al (2013) Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology 145(6):1289–1299PubMedCrossRef
38.
Peterson KA et al (2010) Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 55(5):1313–1319PubMedCrossRef
39.
Lucendo AJ, Arias A, and Molina-Infante J (2016) Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 14(1): p. 13-22 e1PubMedCrossRef
40.
Rubio CA, Sjodahl K, Lagergren J (2006) Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol 125(3):432–437PubMedCrossRef
41.
Haque S, Genta RM (2012) Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut 61(8):1108–1114PubMedCrossRef
42.
Purdy JK et al (2008) Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol 130(4):508–513PubMedCrossRef
43.
Xue Y et al (2015) Lymphocytic esophagitis with CD4 T-cell-predominant intraepithelial lymphocytes and primary esophageal motility abnormalities: a potential novel clinicopathologic entity. Am J Surg Pathol 39(11):1558–1567PubMedCrossRef
44.
Rubio CA, Ichiya T, Schmidt PT (2017 Mar) Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: histological and immunohistochemical findings. J Clin Pathol 70(3):208–216PubMedCrossRef
45.
Ebach DR et al (2011) Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn’s disease. Inflamm Bowel Dis 17(1):45–49PubMedCrossRef
46.
47.
48.
Basseri B et al (2013) Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease. Gastroenterol Hepatol (N Y) 9(8):505–511
49.
Putra J et al (2016) Lymphocytic esophagitis in nonachalasia primary esophageal motility disorders: improved criteria, prevalence, strength of association, and natural history. Am J Surg Pathol 40(12):1679–1685PubMedPubMedCentralCrossRef
50.
Zerbib F, Roman S (2015) Current therapeutic options for esophageal motor disorders as defined by the Chicago Classification. J Clin Gastroenterol 49(6):451–460PubMedCrossRef
51.
Scully C, el-Kom M (1985) Lichen planus: review and update on pathogenesis. J Oral Pathol 14(6):431–458PubMedCrossRef
52.
Lund WS (1976) Treatment of superficial lesions of the mouth and pharynx. J Laryngol Otol 90(1):105–112PubMedCrossRef
53.
Abraham SC et al (2000) Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol 24(12):1678–1682PubMedCrossRef
54.
Chryssostalis A et al (2008) Esophageal lichen planus: a series of eight cases including a patient with esophageal verrucous carcinoma. A case series. Endoscopy 40(9):764–768PubMedCrossRef
55.
Quispel R et al (2009) High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy 41(3):187–193PubMedCrossRef
56.
Salaria SN et al (2013) Lichenoid esophagitis: clinicopathologic overlap with established esophageal lichen planus. Am J Surg Pathol 37(12):1889–1894PubMedCrossRef
57.
Katzka DA et al (2010) Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol 8(9):777–782PubMedCrossRef
58.
Silverman S Jr, Gorsky M, Lozada-Nur F (1985) A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 60(1):30–34PubMedCrossRef
59.
Silverman S Jr et al (1991) A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 72(6):665–670PubMedCrossRef
60.
61.
Tada S et al (1990) Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 36(1):10–14PubMedCrossRef
62.
Costigan DJ, Clouse RE (1983) Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci 28(8):763–765PubMedCrossRef
63.
Lazaraki G et al (2009) A rare case of multiple myeloma initially presenting with pseudoachalasia. Dis Esophagus 22(6):E21–E24PubMedCrossRef
64.
Rubinow A et al (1983) Esophageal manometry in systemic amyloidosis. A study of 30 patients. Am J Med 75(6):951–956PubMedCrossRef
65.
Ip S et al (2016) Sensitivities of biopsy sites in the endoscopic evaluation of graft-versus-host disease: retrospective review from a tertiary center. Dig Dis Sci 61(8):2351–2356PubMedCrossRef
66.
Novak JM et al (1979) Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1(1):9–39PubMedCrossRef
67.
Seaman WB, Ackerman LV (1957) The effect of radiation on the esophagus; a clinical and histologic study of the effects produced by the betatron. Radiology 68(4):534–541PubMedCrossRef
68.
Taggart MW et al (2013) Oesophageal hyperkeratosis: clinicopathological associations. Histopathology 63(4):463–473PubMed
69.
70.
Singhi AD et al (2014) Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Mod Pathol 27(1):38–43PubMedCrossRef
71.
Ezoe Y et al (2011) Epidermoid metaplasia of the esophagus: endoscopic feature and differential diagnosis. Hepato-Gastroenterology 58(107–108):809–813PubMed
72.
Postlethwait RW, Musser AW (1974) Changes in the esophagus in 1,000 autopsy specimens. J Thorac Cardiovasc Surg 68(6):953–956PubMedCrossRef
Metadata
Title
Esophagitis unrelated to reflux disease: current status and emerging diagnostic challenges
Authors
Melanie E. Johncilla
Amitabh Srivastava
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 1/2018
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2238-4

Other articles of this Issue 1/2018

Virchows Archiv 1/2018 Go to the issue

Invited Annual Review Issue

Biopsy diagnosis of colitis: an algorithmic approach

Invited Annual Review Issue

Classification of eosinophilic disorders of the small and large intestine

Invited Annual Review Issue

Gut microbiome: a new player in gastrointestinal disease

Original Article

Navigating the jungles of tropical infectious gastrointestinal pathology: a pattern-based approach to the endoscopic biopsy

Original Article

Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD

Invited Annual Review Issue

Immune checkpoint inhibitor colitis: the flip side of the wonder drugs